Perrigo Company plc(PRGO) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -12.51 | Insider Own | 0.43% | Shs Outstand | 138.7M | Perf Week | -6.21% |
| Market Cap | 1.89B | Forward P/E | 5.58 | EPS next Y | 9.77% | Insider Trans | - | Shs Float | 138.2M | Perf Month | 5.76% |
| Enterprise Value | 4.94B | PEG | - | EPS next Q | 0.52 | Inst Own | 111.32% | Short Float | 16.05% | Perf Quarter | 21.67% |
| Income | -1.73B | P/S | 0.45 | EPS this Y | -19.39% | Inst Trans | 3.83% | Short Ratio | 6.68 | Perf Half Y | 38.53% |
| Sales | 4.14B | P/B | 0.75 | EPS next 5Y | -0.67% | ROA | -19.24% | Short Interest | 22.18M | Perf YTD | -2.37% |
| Book/sh | 18.14 | P/C | 4.72 | EPS past 3/5Y | -114.32% -53.83% | ROE | -48.75% | 52W High | -40% ($22.65) | Perf Year | -38.56% |
| Cash/sh | 2.88 | P/FCF | 15.81 | Sales past 3/5Y | -1.5% 0.8% | ROIC | -29.22% | 52W Low | 47.32% ($9.23) | Perf 3Y | -59.86% |
| Dividend Est. | $1.16 (8.5%) | EV/EBITDA | 7.07 | EPS Y/Y TTM | -2138.82% | Gross Margin | 33.32% | Volatility(W/M) | 4.36% 4.01% | Perf 5Y | -68.89% |
| Dividend TTM | 1.16 | EV/Sales | 1.19 | Sales Y/Y TTM | -4.18% | Oper. Margin | 6.42% | ATR (14) | 0.61 | Perf 10Y | -84.68% |
| Dividend Ex-Date | 2026/8/28 | Quick Ratio | 1.32 | EPS Q/Q | 977.8% | Profit Margin | -41.85% | RSI (14) | 50.5 | Recom | 2.4 |
| Dividend Gr. 3/5Y | 3.71% 5.21% | Current Ratio | 2.32 | Sales Q/Q | -3.17% | SMA20 | -3.34% ($14.06) | Beta | 0.69 | Target Price | $15.33 |
| Payout | - | Debt/Eq | 1.37 | Earnings | 2026/8/5 | SMA50 | 11.51% ($12.19) | Rel Volume | 0.6 | Prev Close | $14.34 |
| Employees | 8100 | LT Debt/Eq | 1.36 | EPS/Sales Surpr. | 28.87% 0.72% | SMA200 | 11.23% ($12.22) | Avg Volume(3M) | 3.32M | Price | $13.59 |
| IPO | 1991/12/17 | Option/Short | Yes/Yes | Trades | 17738 | Volume | 1,982,949 | Change | -5.23% |
Company
PRGO is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 A global healthcare company that manufactures and sells consumer self-care products. It produces and supplies over-the-counter (OTC) medicines, infant nutrition, and women's health products under its own brands and retailer private labels, supported by a global manufacturing and distribution network. The company has established itself as a healthcare business focused specifically on consumer self-care.
Over the past 1 year, roughly in the middle
40% below its 1-year high.
PRGO has weak earning power
6.42% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -19.4% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -59.9% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 8.50% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 111.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DIVY 0.04%
PEY 0.03%
PJP 0.02%
XSHD 0.02%
DIV 0.02%It ranks #4 in the industry
Based on market cap of $2B.
PRGO $2B PER -
TAK $58B PER -
TEVA $42B PER 61.1
HLN $41B PER 19.0
FAQ
What kind of company is PRGO?
PRGO belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of PRGO?
The market cap of PRGO is approximately $1.9B, ranking 2,154 within its sector.
Does PRGO pay dividends?
PRGO has a dividend yield of approximately 8.50%, with an annual dividend of $1.16.
What is the 52-week high and low for PRGO?
PRGO has recorded a 52-week high of $22.65 and a low of $9.23.
